|
|
Volumn 63, Issue 3, 2004, Pages 613-618
|
|
Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
CHORIONIC GONADOTROPIN BETA SUBUNIT;
ENZYME INHIBITOR;
HYBRID PROTEIN;
PRODRUG;
THYMIDINE KINASE;
TUMOR MARKER;
TUMOR PROTEIN;
ADENOVIRUS;
ANIMAL;
ARTICLE;
BAGG ALBINO MOUSE;
BIOSYNTHESIS;
BLADDER TUMOR;
BLOOD;
CARCINOMA;
DRUG SCREENING;
EMBRYONAL CARCINOMA;
GENE THERAPY;
GENE VECTOR;
GENETICS;
HUMAN;
MALE;
METABOLISM;
MOUSE;
NUDE MOUSE;
PATHOLOGY;
PROMOTER REGION;
PROSTATE TUMOR;
SALVAGE THERAPY;
SUICIDE TRANSGENE;
TESTIS TUMOR;
TUMOR CELL LINE;
ACYCLOVIR;
ADENOVIRIDAE;
ANIMALS;
CARCINOMA;
CARCINOMA, EMBRYONAL;
CELL LINE, TUMOR;
CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN;
ENZYME INHIBITORS;
GENE THERAPY;
GENES, TRANSGENIC, SUICIDE;
GENETIC VECTORS;
HUMANS;
MALE;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
NEOPLASM PROTEINS;
PRODRUGS;
PROMOTER REGIONS (GENETICS);
PROSTATIC NEOPLASMS;
RECOMBINANT FUSION PROTEINS;
SALVAGE THERAPY;
TESTICULAR NEOPLASMS;
THYMIDINE KINASE;
TUMOR MARKERS, BIOLOGICAL;
URINARY BLADDER NEOPLASMS;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
MLCS;
MLOWN;
|
|
EID: 2942631096
PISSN: None
EISSN: 15279995
Source Type: Journal
DOI: 10.1016/j.urology.2003.09.054 Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
